A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults (DYNAMIC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04900038 |
|
Recruitment Status :
Active, not recruiting
First Posted : May 25, 2021
Last Update Posted : January 25, 2023
|
Sponsor:
ViiV Healthcare
Collaborator:
Syneos Health
Information provided by (Responsible Party):
ViiV Healthcare
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | November 22, 2022 |
| Estimated Study Completion Date : | June 7, 2023 |